Real-time enrollment status for this moderate to severe plaque psoriasis clinical trial
Current Status
Recruiting
Checked: August 30, 2026 at 1:17 PM UTC
| NCT Number | NCT06888193 |
| Recruiting Status | Recruiting |
| Condition | Moderate to Severe Plaque Psoriasis |
| Phase | PHASE1 |
| Target Enrollment | 20 participants |
| Active Locations | 6 sites in the US |
| Sponsor | UCB Biopharma SRL |
| Last Updated on CT.gov | July 17, 2026 (Jul 17, 2026) |
As of August 30, 2026: Clinical trial NCT06888193 is currently recruiting participants. This phase1 study for moderate to severe plaque psoriasis is actively seeking new participants at 6 locations across the United States. The study is sponsored by UCB Biopharma SRL. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06888193 is actively recruiting participants as of August 30, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06888193 was last updated Jul 17, 2026 (July 17, 2026). HelloStudys verifies this status automatically.